Shalby Limited (NSE:SHALBY) submitted copies of newspaper advertisements published on August 13, 2026, confirming the board-approved unaudited financial results for the quarter ended June 30, 2026, covering both standalone and consolidated performance as required under SEBI LODR Regulations 30 and 47.
Key Highlights
- Standalone total income from operations for Q1 FY27 stood at Rs 2,537.91 million, compared with Rs 2,365.64 million in Q1 FY26, reflecting year-on-year growth.
- Standalone net profit after tax for the quarter was Rs 250.66 million, against Rs 256.95 million in the corresponding quarter of the previous year.
- Consolidated total income from operations reached Rs 3,312.24 million for Q1 FY27, compared with Rs 2,964.26 million in Q1 FY26.
- The board of directors approved these results at its meeting held on August 12, 2026, and the advertisement appeared in Financial Express in both English and Gujarati editions.
About the Company
Shalby Limited (NSE:SHALBY) is a multi-specialty hospital chain headquartered at S. G. Road, Ahmedabad, Gujarat, with its registered office at Shalby Multi-Specialty Hospitals opposite Karnavati Club. The company operates across the healthcare sector, providing tertiary and secondary care services including orthopaedics, oncology, cardiac care, and other specialties. It holds CIN L85110GJ2004PLC044667 and is listed on both NSE and BSE.
Announcement in Detail
The filing, referenced as Shalby/SE/2026-27/40 and dated August 13, 2026, was submitted by Vice President and Company Secretary Tushar Shah. It enclosed copies of the newspaper advertisement published on the same date in Financial Express confirming the extract of unaudited financial results for the quarter ended June 30, 2026, as mandated under Regulation 33 of SEBI LODR Regulations 2015.
On a standalone basis, earnings per share for Q1 FY27 were Rs 2.33 (basic and diluted), against Rs 2.39 in Q1 FY26. Consolidated EPS stood at Rs 0.98 for Q1 FY27, up from Rs 0.71 in the same quarter of the prior year. Paid-up equity share capital as at June 30, 2026 was Rs 1,075.26 million, net of treasury shares, with a face value of Rs 10 per share.
Impact on Investors
The filing shows standalone net profit after tax declined marginally from Rs 256.95 million in Q1 FY26 to Rs 250.66 million in Q1 FY27, while standalone revenue grew over the same period. Investors will note that consolidated net profit after tax improved to Rs 104.96 million from Rs 76.78 million year-on-year, suggesting the consolidated entity returned a stronger profit trajectory at the subsidiary level compared with the prior corresponding quarter.
Shareholders will observe that the full detailed financial results, including all schedules and notes, are available on the BSE and NSE exchange portals as well as on the company's official filing page, allowing a more granular review beyond the extract published in the newspaper advertisement.
Sector / Market Context
India's private healthcare sector continues to expand, with the industry estimated to account for a significant share of the country's total hospital bed capacity. The National Health Authority and Ministry of Health data indicate sustained growth in healthcare infrastructure investment across Tier 1 and Tier 2 cities. Multi-specialty hospital chains listed on Indian exchanges have reported increased patient volumes and procedural revenue following post-pandemic recovery, with orthopaedics and cardiac care among the highest-growth segments in private hospital revenue per the Confederation of Indian Industry's healthcare committee reports.